In this paper, two IBU-NIC cocrystal polymorphs formed between ibuprofen (IBU) and nicotinamide (NIC) were synthesized by solvent drop grinding, solution evaporation and melting recrystallization. IBU ...

Dermatologists explain which therapies to avoid, which to keep even as they campaign for a regulatory mechanism for ...

Niagen Bioscience can either commercialise the drug candidate independently or sublicense to a strategic pharmaceutical ...

Niagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...

Investing.com -- Niagen Bioscience Inc (NASDAQ: NAGE) stock rose 2% after the company announced an exclusive worldwide commercial license agreement with Norway’s Haukeland University Hospital to ...